- Home
- SNY vs WELL Comparison
SNY vs WELL Comparison
Compare SNY & WELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- WELL
- Stock Information
- Founded
- SNY 1994
- WELL 1970
- Country
- SNY France
- WELL United States
- Employees
- SNY N/A
- WELL N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- WELL Real Estate Investment Trusts
- Sector
- SNY Health Care
- WELL Real Estate
- Exchange
- SNY Nasdaq
- WELL Nasdaq
- Market Cap
- SNY 116.1B
- WELL 117.8B
- IPO Year
- SNY N/A
- WELL N/A
- Fundamental
- Price
- SNY $49.11
- WELL $173.12
- Analyst Decision
- SNY Buy
- WELL Strong Buy
- Analyst Count
- SNY 4
- WELL 10
- Target Price
- SNY $61.50
- WELL $186.70
- AVG Volume (30 Days)
- SNY 3.9M
- WELL 3.7M
- Earning Date
- SNY 10-24-2025
- WELL 10-27-2025
- Dividend Yield
- SNY 3.25%
- WELL 1.71%
- EPS Growth
- SNY 118.56
- WELL 67.69
- EPS
- SNY 8.65
- WELL 1.76
- Revenue
- SNY $53,714,621,258.00
- WELL $9,277,824,000.00
- Revenue This Year
- SNY $1.53
- WELL $29.27
- Revenue Next Year
- SNY $7.06
- WELL $13.97
- P/E Ratio
- SNY $5.69
- WELL $98.27
- Revenue Growth
- SNY 15.65
- WELL 31.96
- 52 Week Low
- SNY $44.62
- WELL $122.34
- 52 Week High
- SNY $60.12
- WELL $180.40
- Technical
- Relative Strength Index (RSI)
- SNY 54.77
- WELL 54.11
- Support Level
- SNY $44.62
- WELL $174.89
- Resistance Level
- SNY $51.05
- WELL $180.40
- Average True Range (ATR)
- SNY 0.83
- WELL 2.71
- MACD
- SNY 0.43
- WELL 0.05
- Stochastic Oscillator
- SNY 68.73
- WELL 51.51
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,391 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.